Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00504010 · ClinicalTrials.gov registry record · Phase 1

The Role of Arnica on Muscle Pain Following Eccentric Exercise

A Phase 1 study of Exercise and Muscles, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
Phase 1
Development phase
55
Enrollment target
1
Study location

NCT00504010 is a Phase 1 study of Exercise and Muscles that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 55 participants, below the 8,910-participant average among 57 other Exercise trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00504010, a Phase 1 study of Exercise and Muscles, has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
Phase 1
Development phase
55 participants
Enrollment target
1
Study location

Study Summary

Arnica in a topical gel formulation will be compared to a placebo to determine whether it decreases muscle soreness following leg exercise when applied to the legs.

Interventions

  • DRUG Arnica Montana
  • DRUG placebo cream

Study Locations (1)

Texas

  • Memorial Family Medicine - Houston

Trial Details

FieldValue
Enrollment Target 55 participants
Start Date 2007-08
Est. Completion 2008-09
Phase Phase 1

What the Registry Record Tells You About NCT00504010

The ClinicalTrials.gov registry entry for NCT00504010 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 8,910-participant average among 57 other Exercise trials with a reported enrollment target (99% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Exercise appearing as the primary indexed condition, and to 2 interventions - of which Arnica Montana is the first listed.

NCT00504010 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT00504010 about?

NCT00504010 is a clinical study titled "The Role of Arnica on Muscle Pain Following Eccentric Exercise". Arnica in a topical gel formulation will be compared to a placebo to determine whether it decreases muscle soreness following leg exercise when applied to the legs.

What is the current status of trial NCT00504010?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 55 participants. The study started on 2007-08. Estimated completion is 2008-09.

What conditions does trial NCT00504010 study?

This clinical trial studies the following conditions: Exercise, Muscles, Arnica.

What interventions are being tested in trial NCT00504010?

The interventions under investigation include: Arnica Montana (DRUG), placebo cream (DRUG).

Who is sponsoring clinical trial NCT00504010?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00504010 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Exercise

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.